Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP vs NT-proBNP with Entresto in Heart Failure
NCT04107220Unknown
- Sponsor
- Unity Health Toronto
- Start
- Jun 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sacubitril + valsartan in heart failure (HF), sponsored by Unity Health Toronto. Primary endpoints: B-type Natriuretic Peptide at 180 days and N-terminal pro-B-type Natriuretic Peptide at 180 days. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04107220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04107220.